These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 25986529

  • 21. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.
    BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449
    [Abstract] [Full Text] [Related]

  • 22. PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism.
    Pan Q, Chen MM, Zhang RN, Wang YQ, Zheng RD, Mi YQ, Liu WB, Shen F, Su Q, Fan JG.
    J Diabetes Res; 2017 Dec 19; 2017():4740124. PubMed ID: 28695131
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
    Kuttner CS, Mancina R, Wagenpfeil G, Lammert F, Stokes CS.
    Lifestyle Genom; 2019 Dec 19; 12(1-6):10-17. PubMed ID: 31454802
    [Abstract] [Full Text] [Related]

  • 25. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY.
    World J Gastroenterol; 2015 Jan 21; 21(3):794-802. PubMed ID: 25624712
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr 21; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 30. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study.
    Trunečka P, Míková I, Dlouhá D, Hubáček JA, Honsová E, Kolesár L, Lánská V, Fraňková S, Šperl J, Jirsa M, Poledne R.
    Dig Liver Dis; 2018 May 21; 50(5):490-495. PubMed ID: 29396131
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
    Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S, Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N.
    Clin Microbiol Infect; 2016 Apr 21; 22(4):372-378. PubMed ID: 26806136
    [Abstract] [Full Text] [Related]

  • 34. Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.
    Franko A, Merkel D, Kovarova M, Hoene M, Jaghutriz BA, Heni M, Königsrainer A, Papan C, Lehr S, Häring HU, Peter A.
    Nutrients; 2018 Sep 17; 10(9):. PubMed ID: 30227635
    [Abstract] [Full Text] [Related]

  • 35. PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Mancina RM, Spagnuolo R, Milano M, Brogneri S, Morrone A, Cosco C, Lazzaro V, Russo C, Ferro Y, Pingitore P, Pujia A, Montalcini T, Doldo P, Garieri P, Piodi L, Caprioli F, Valenti L, Romeo S.
    Inflamm Bowel Dis; 2016 Jan 17; 22(1):134-40. PubMed ID: 26355465
    [Abstract] [Full Text] [Related]

  • 36. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, Pilia S, Huang-Doran I, Cossu E, Loche S, Baroni MG.
    J Hepatol; 2010 Aug 17; 53(2):335-8. PubMed ID: 20546964
    [Abstract] [Full Text] [Related]

  • 37. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R, McLean J, Lazo M, Brancati FL, Hirschhorn JN, Borecki IB, Harris TB, Genetics of Obesity-Related Liver Disease (GOLD) Consortium, Nguyen T, Kamel IR, Bonekamp S, Eberhardt MS, Clark JM, Kao WH, Speliotes EK.
    Clin Gastroenterol Hepatol; 2013 Sep 17; 11(9):1183-1190.e2. PubMed ID: 23416328
    [Abstract] [Full Text] [Related]

  • 38. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
    Pirazzi C, Adiels M, Burza MA, Mancina RM, Levin M, Ståhlman M, Taskinen MR, Orho-Melander M, Perman J, Pujia A, Andersson L, Maglio C, Montalcini T, Wiklund O, Borén J, Romeo S.
    J Hepatol; 2012 Dec 17; 57(6):1276-82. PubMed ID: 22878467
    [Abstract] [Full Text] [Related]

  • 39. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
    Mandorfer M, Scheiner B, Stättermayer AF, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P, Ferlitsch A.
    Aliment Pharmacol Ther; 2018 Aug 17; 48(4):451-459. PubMed ID: 29956823
    [Abstract] [Full Text] [Related]

  • 40. Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters.
    Crisan D, Grigorescu M, Crisan N, Craciun R, Lupsor M, Radu C, Grigorescu MD, Suciu A, Epure F, Avram L, Leach N.
    J Physiol Pharmacol; 2019 Aug 17; 70(4):. PubMed ID: 31642820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.